My days at Stillwater prison
Hanson, A.S.
Minnesota Medicine 99(2): 20-21
2016
ISSN/ISBN: 0026-556X PMID: 27089669 Document Number: 688410
Document emailed within 1 workday
Related Documents
Chimphambano, C.; Komolafe, O.O.; Muula, A.S. 2007: HIV prevalence among prison inmates in a central prison in southern Malawi, 2005 Tropical Doctor 37(4): 226-228Hepburn, M.J.; Dooley, D.P.; Skidmore, P.J.; Ellis, M.W.; Starnes, W.F.; Hasewinkle, W.C. 2004: Comparison of short-course (5 days) and standard (10 days) treatment for uncomplicated cellulitis Archives of Internal Medicine 164(15): 1669-1674
Tobal, N.; Roumy, J.; Herault, S.; Fomina, G.; Alferova, I.; Arbeille, P. 2001: Cardiac, cerebral and lower limb hemodynamic changes, during HDT (5 days to 42 d) and space flights (7 days to 6 months) Journal of Gravitational Physiology: a Journal of the International Society for Gravitational Physiology 8(1): P53-P54
1984: With different working schedule in a new nursing system. 4 days work--3 days off? Krankenpflege. Soins Infirmiers 77(5): 69-70
Elgjo, R.F. 1981: Thoughts on the official Swedish investigation "The final stages of life". more essential to put life in the days than add days to the life Nordisk Medicin 96(2): 46-47
MacGregor, A. 1997: The prison nurse Nursing Times 93(9): 12
Schachtel, M. 1997: Health in prison: what is new? Revue de l'Infirmiere 26: 13-20
Haines, J.D. 1985: Prison riot! Journal of the Oklahoma State Medical Association 78(4): 108-111
Henrion, R. 2013: Which procreation in prison? La Revue du Praticien 63(3): 307-308
Loendersloot, E.W. 1985: Demonstration of effectiveness and tolerability of terconazole 80-mg vaginal suppositories (3 days) versus terconazole 240-mg vaginal suppositories (1 day) versus clotrimazole 200-mg vaginal tablets (3 days) in non-pregnant women with vulvovaginal candidosis Gynakologische Rundschau 25(Suppl): 99-104
Valantin, M.-A. 2013: Infectious diseases in prison La Revue du Praticien 63(1): 86-87
Joneja, M.G.; Travill, A.A.; Scott, G.D. 1971: Another XYY case in a prison population Canadian Medical Association Journal 104(5): 424-425
Wines, J.D.; Saitz, R.; Samet, J.H. 2007: Mortality after release from prison New England Journal of Medicine 356(17): 1785-1786; Author Reply 1786-1787
Bourgoin, N. 1993: Mortality due to suicide in prison Revue d'Epidemiologie et de Sante Publique 41(2): 146-154
Angora, B.éh.é; Assemien, J.d.'A.; Laurent, A.; Febro, V.; Coulibaly-Offia, M.; Masumbuko, J.-M.; Kakou, R.A.; Traore, V.E.; Eholie, S.; Brucker, G.; Lacoste, D.; Raguin, G. 2011: HIV in prison in low income countries Aids 25(9): 1244-1246
Kościuszkowa, J. 1972: A year at the Montelupi prison Przeglad Lekarski 29(1): 191-196
Cullen, R. 1988: Hepatitis B at Mt Eden prison New Zealand Medical Journal 101(838): 25-26
Carter, J.H. 1981: The use of psychotropics in the prison setting North Carolina Medical Journal 42(9): 645-647
Bourgeois, D. 1997: Sleep disorders in prison L'Encephale 23(3): 180-183
1995: Prison policies put inmates at risk Bmj 310(6975): 278-283